Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (6)
Filtered (6)
Filter

Filter

6 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(6) Reset
Show (6)
Cancel
Apply(6) Reset
6 entriesShowing 1–6
Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiverNamed profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.
Palladia / Toceranib · Prescription Drug · Targeted Therapy · Palladia · Dogs · After Targeted Therapy · During Targeted Therapy

Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy

Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…

Read more
Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiverNamed profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.
Laverdia / Verdinexor · Prescription Drug · Targeted Therapy · Laverdia · Dogs · After Targeted Therapy · During Targeted Therapy

Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma

Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…

Read more
Veterinarian reviewing mushroom reference materials and unbranded supplement formats with a dogNamed profile Four Leaf Rover Turkey Tail Mushroom: Product ProfileRepresentative category illustration – no product packaging is shown.
Immune-support Supplement · Mushroom Supplement · Supplement · Four Leaf Rover Turkey Tail · Dogs · Long-term Management · Limited / Emerging Evidence

Four Leaf Rover Turkey Tail Mushroom: Product Profile

Four Leaf Rover Turkey Tail Mushroom is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.

Read more
Veterinarian reviewing an immune pathway concept and an unbranded biologic treatment with a dog caregiverNamed profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.
Immunotherapy · Prescription Drug · Gilvetmab · Dogs · During Targeted Therapy · New Diagnosis · Published Study

Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile

gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing hydration and digestive symptom monitoring with a dog caregiverNamed profile Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea SupportRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Canalevia-CA1 · Dogs · After Chemotherapy · During Chemotherapy · Published Study

Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea Support

crofelemer delayed-release tablets is covered as prescription antisecretory gastrointestinal medicine; supportive care, not antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more